Skip to main content
Top
Published in: Malaria Journal 1/2016

Open Access 01-12-2016 | Research

The diagnostic accuracy of the hand-held Raman spectrometer for the identification of anti-malarial drugs

Authors: Benjamin J. Visser, Sophia G. de Vries, Emmanuel B. Bache, Janneke Meerveld-Gerrits, Daniëlle Kroon, Jimmy Boersma, Selidji T. Agnandji, Michèle van Vugt, Martin P. Grobusch

Published in: Malaria Journal | Issue 1/2016

Login to get access

Abstract

Background

There is a need for accurate and field-applicable instruments for the evaluation of the quality of anti-malarial drugs. The aim of this study was to determine the diagnostic accuracy of the NanoRam®, a handheld Raman spectrometer (RS), to identify anti-malarial drugs.

Methods

In total, 289 anti-malarial drugs collected in a randomized field survey in Gabon were evaluated. The samples were compared with authentic products as supplied by the official manufacturer. To determine the sensitivity and specificity of the handheld NanoRam® spectrometer in the identification of anti-malarial drugs, a two-gate reversed-flow design was applied. The standards for reporting of diagnostic accuracy studies (STARD) were followed. The index test was the handheld RS. The reference test standards were thin layer chromatography and high performance liquid chromatography with ultraviolet photo diode array detection.

Results

The sensitivity [95 % confidence interval (95 % CI)] and specificity of the RS to correctly identify an anti-malarial drug were 100 % (95 % CI 94.9–100 %) and 96 % (95 % CI 92.3–99.0 %), respectively. The RS could not differentiate between different batches of the same product or different manufacturers of the same product. Intra-observer agreement for 289 samples was 100 %. The average time to conduct the RS was 15 s per sample compared to 45 min per sample for TLC.

Conclusion

The handheld RS holds promise as an easy-to-use, quick and field-applicable instrument for the evaluation of quality of anti-malarial drugs, potentially empowering pharmacists, drug inspectors and medical regulatory authorities.
Trial registration NTR4341 (Dutch Trial Registry)
Appendix
Available only for authorised users
Literature
1.
go back to reference Newton PN, Lee SJ, Goodman C, Fernandez FM, Yeung S, Phanouvong S, et al. Guidelines for field surveys of the quality of medicines: a proposal. PLoS Med. 2009;6:e52.CrossRefPubMed Newton PN, Lee SJ, Goodman C, Fernandez FM, Yeung S, Phanouvong S, et al. Guidelines for field surveys of the quality of medicines: a proposal. PLoS Med. 2009;6:e52.CrossRefPubMed
2.
go back to reference Chaccour C, Kaur H, Del Pozo JL. Falsified antimalarials: a minireview. Expert Rev Anti Infect Ther. 2015;13:505–9.PubMed Chaccour C, Kaur H, Del Pozo JL. Falsified antimalarials: a minireview. Expert Rev Anti Infect Ther. 2015;13:505–9.PubMed
3.
go back to reference Tabernero P, Fernandez FM, Green M, Guerin PJ, Newton PN. Mind the gaps–the epidemiology of poor-quality anti-malarials in the malarious world–analysis of the WorldWide antimalarial resistance network database. Malar J. 2014;13:139.CrossRefPubMedPubMedCentral Tabernero P, Fernandez FM, Green M, Guerin PJ, Newton PN. Mind the gaps–the epidemiology of poor-quality anti-malarials in the malarious world–analysis of the WorldWide antimalarial resistance network database. Malar J. 2014;13:139.CrossRefPubMedPubMedCentral
4.
go back to reference Almuzaini T, Choonara I, Sammons H. Substandard and counterfeit medicines: a systematic review of the literature. BMJ Open. 2013;3:e002923.PubMedPubMedCentral Almuzaini T, Choonara I, Sammons H. Substandard and counterfeit medicines: a systematic review of the literature. BMJ Open. 2013;3:e002923.PubMedPubMedCentral
5.
go back to reference Nayyar GM, Breman JG, Newton PN, Herrington J. Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa. Lancet Infect Dis. 2012;12:488–96.CrossRefPubMed Nayyar GM, Breman JG, Newton PN, Herrington J. Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa. Lancet Infect Dis. 2012;12:488–96.CrossRefPubMed
6.
go back to reference Newton PN, Amin AA, Bird C, Passmore P, Dukes G, Tomson G, et al. The primacy of public health considerations in defining poor quality medicines. PLoS Med. 2011;8:e1001139.CrossRefPubMedPubMedCentral Newton PN, Amin AA, Bird C, Passmore P, Dukes G, Tomson G, et al. The primacy of public health considerations in defining poor quality medicines. PLoS Med. 2011;8:e1001139.CrossRefPubMedPubMedCentral
7.
go back to reference Newton PN, Green MD, Mildenhall DC, Plancon A, Nettey H, Nyadong L, et al. Poor quality vital anti-malarials in Africa—an urgent neglected public health priority. Malar J. 2011;10:352.CrossRefPubMedPubMedCentral Newton PN, Green MD, Mildenhall DC, Plancon A, Nettey H, Nyadong L, et al. Poor quality vital anti-malarials in Africa—an urgent neglected public health priority. Malar J. 2011;10:352.CrossRefPubMedPubMedCentral
8.
go back to reference Newton PN, Tabernero P, Dwivedi P, Culzoni MJ, Monge ME, Swamidoss I, et al. Falsified medicines in Africa: all talk, no action. Lancet Glob Health. 2014;2:e509–10.CrossRefPubMed Newton PN, Tabernero P, Dwivedi P, Culzoni MJ, Monge ME, Swamidoss I, et al. Falsified medicines in Africa: all talk, no action. Lancet Glob Health. 2014;2:e509–10.CrossRefPubMed
10.
go back to reference van Vugt M, van Beest A, Sicuri E, van Tulder M, Grobusch MP. Malaria treatment and prophylaxis in endemic and nonendemic countries: evidence on strategies and their cost-effectiveness. Future Microbiol. 2011;6:1485–500.CrossRefPubMed van Vugt M, van Beest A, Sicuri E, van Tulder M, Grobusch MP. Malaria treatment and prophylaxis in endemic and nonendemic countries: evidence on strategies and their cost-effectiveness. Future Microbiol. 2011;6:1485–500.CrossRefPubMed
11.
go back to reference Visser BJ, van Vugt M, Grobusch MP. Malaria: an update on current chemotherapy. Expert Opin Pharmacother. 2014;15:2219–54.CrossRefPubMed Visser BJ, van Vugt M, Grobusch MP. Malaria: an update on current chemotherapy. Expert Opin Pharmacother. 2014;15:2219–54.CrossRefPubMed
12.
go back to reference Visser BJ, Wieten RW, Kroon D, Nagel IM, Belard S, van Vugt M, et al. Efficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review. Malar J. 2014;13:463.CrossRefPubMedPubMedCentral Visser BJ, Wieten RW, Kroon D, Nagel IM, Belard S, van Vugt M, et al. Efficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review. Malar J. 2014;13:463.CrossRefPubMedPubMedCentral
13.
go back to reference Grobusch MP, van Vugt M. Malaria therapy: where do we stand, what next? Future Microbiol. 2010;5:1447–9.CrossRefPubMed Grobusch MP, van Vugt M. Malaria therapy: where do we stand, what next? Future Microbiol. 2010;5:1447–9.CrossRefPubMed
14.
go back to reference Kelesidis T, Falagas ME. Substandard/counterfeit antimicrobial drugs. Clin Microbiol Rev. 2015;28:443–64.CrossRefPubMed Kelesidis T, Falagas ME. Substandard/counterfeit antimicrobial drugs. Clin Microbiol Rev. 2015;28:443–64.CrossRefPubMed
15.
go back to reference Renschler JP, Walters KM, Newton PN, Laxminarayan R. Estimated under-five deaths associated with poor-quality antimalarials in sub-saharan Africa. Am J Trop Med Hyg. 2015;92:119–26.CrossRefPubMedPubMedCentral Renschler JP, Walters KM, Newton PN, Laxminarayan R. Estimated under-five deaths associated with poor-quality antimalarials in sub-saharan Africa. Am J Trop Med Hyg. 2015;92:119–26.CrossRefPubMedPubMedCentral
17.
go back to reference White NJ, Pongtavornpinyo W, Maude RJ, Saralamba S, Aguas R, Stepniewska K, et al. Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance. Malar J. 2009;8:253.CrossRefPubMedPubMedCentral White NJ, Pongtavornpinyo W, Maude RJ, Saralamba S, Aguas R, Stepniewska K, et al. Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance. Malar J. 2009;8:253.CrossRefPubMedPubMedCentral
18.
21.
go back to reference Visser BJ, Meerveld-Gerrits J, Kroon D, Mougoula J, Vingerling R, Bache E, et al. Assessing the quality of anti-malarial drugs from Gabonese pharmacies using the MiniLab(R): a field study. Malar J. 2015;14:273.CrossRefPubMedPubMedCentral Visser BJ, Meerveld-Gerrits J, Kroon D, Mougoula J, Vingerling R, Bache E, et al. Assessing the quality of anti-malarial drugs from Gabonese pharmacies using the MiniLab(R): a field study. Malar J. 2015;14:273.CrossRefPubMedPubMedCentral
22.
go back to reference Degardin K, Roggo Y, Been F, Margot P. Detection and chemical profiling of medicine counterfeits by Raman spectroscopy and chemometrics. Anal Chim Acta. 2011;705:334–41.CrossRefPubMed Degardin K, Roggo Y, Been F, Margot P. Detection and chemical profiling of medicine counterfeits by Raman spectroscopy and chemometrics. Anal Chim Acta. 2011;705:334–41.CrossRefPubMed
23.
go back to reference Kiehntopf M, Monch B, Salzer R, Kupfer M, Hartmann M. Quality control of cytotoxic drug preparations by means of Raman spectroscopy. Pharmazie. 2012;67:95–6.PubMed Kiehntopf M, Monch B, Salzer R, Kupfer M, Hartmann M. Quality control of cytotoxic drug preparations by means of Raman spectroscopy. Pharmazie. 2012;67:95–6.PubMed
24.
go back to reference Hajjou M, Qin Y, Bradby S, Bempong D, Lukulay P. Assessment of the performance of a handheld Raman device for potential use as a screening tool in evaluating medicines quality. J Pharm Biomed Anal. 2013;74:47–55.CrossRefPubMed Hajjou M, Qin Y, Bradby S, Bempong D, Lukulay P. Assessment of the performance of a handheld Raman device for potential use as a screening tool in evaluating medicines quality. J Pharm Biomed Anal. 2013;74:47–55.CrossRefPubMed
25.
go back to reference de Veij M, Vandenabeele P, Hall KA, Fernandez FM, Green MD, White NJ, et al. Fast detection and identification of counterfeit antimalarial tablets by Raman spectroscopy. J Raman Spectrosc. 2007;38:181–7.CrossRef de Veij M, Vandenabeele P, Hall KA, Fernandez FM, Green MD, White NJ, et al. Fast detection and identification of counterfeit antimalarial tablets by Raman spectroscopy. J Raman Spectrosc. 2007;38:181–7.CrossRef
27.
go back to reference Visser BJ, Buijink AW, Grobusch MP. Reporting of medical research costs. Improving transparency and reproducibility of medical research. Methods Inf Med. 2014;53:329–31.CrossRefPubMed Visser BJ, Buijink AW, Grobusch MP. Reporting of medical research costs. Improving transparency and reproducibility of medical research. Methods Inf Med. 2014;53:329–31.CrossRefPubMed
28.
go back to reference Bate R, Tren R, Mooney L, Hess K, Mitra B, Debroy B, et al. Pilot study of essential drug quality in two major cities in India. PLoS One. 2009;4:e6003.CrossRefPubMedPubMedCentral Bate R, Tren R, Mooney L, Hess K, Mitra B, Debroy B, et al. Pilot study of essential drug quality in two major cities in India. PLoS One. 2009;4:e6003.CrossRefPubMedPubMedCentral
29.
30.
go back to reference Kaur H, Green MD, Hostetler DM, Fernández FM, Newton PN. Antimalarial drug quality: methods to detect suspect drugs. Therapy. 2010;7:49–57.CrossRef Kaur H, Green MD, Hostetler DM, Fernández FM, Newton PN. Antimalarial drug quality: methods to detect suspect drugs. Therapy. 2010;7:49–57.CrossRef
31.
go back to reference Quinn MF. Relation of observer agreement to accuracy according to a two-receiver signal detection model of diagnosis. Med Decis Making. 1989;9:196–206.CrossRefPubMed Quinn MF. Relation of observer agreement to accuracy according to a two-receiver signal detection model of diagnosis. Med Decis Making. 1989;9:196–206.CrossRefPubMed
32.
go back to reference Paudel A, Raijada D, Rantanen J. Raman spectroscopy in pharmaceutical product design. Adv Drug Deliv Rev. 2015;89:3–20.CrossRefPubMed Paudel A, Raijada D, Rantanen J. Raman spectroscopy in pharmaceutical product design. Adv Drug Deliv Rev. 2015;89:3–20.CrossRefPubMed
33.
go back to reference Blevins RD, Plunkett R. Formulas for natural frequency and mode shape. J Appl Mech. 1980;47:461.CrossRef Blevins RD, Plunkett R. Formulas for natural frequency and mode shape. J Appl Mech. 1980;47:461.CrossRef
34.
go back to reference Kim HH. Endoscopic Raman spectroscopy for molecular fingerprinting of gastric cancer: principle to implementation. Biomed Res Int. 2015:670121. Kim HH. Endoscopic Raman spectroscopy for molecular fingerprinting of gastric cancer: principle to implementation. Biomed Res Int. 2015:670121.
36.
go back to reference Committee NP. Pharmacopoeia of the People’s Republic of China. Part 2010, 1. p. 392–3. Committee NP. Pharmacopoeia of the People’s Republic of China. Part 2010, 1. p. 392–3.
37.
go back to reference Reader J, Corliss CH, Wiese WL, Martin GA. Wavelengths and transition probabilities for atoms and atomic ions: part 1. Wavelengths, part 2. Transition probabilities. NSRDS-NBS. vol 68, 1. 1980. Reader J, Corliss CH, Wiese WL, Martin GA. Wavelengths and transition probabilities for atoms and atomic ions: part 1. Wavelengths, part 2. Transition probabilities. NSRDS-NBS. vol 68, 1. 1980.
38.
go back to reference Lin-Vien D, Colthup NB, Fateley WG, Grasselli JG. The handbook of infrared and Raman characteristic frequencies of organic molecules. Elsevier; 1991. Lin-Vien D, Colthup NB, Fateley WG, Grasselli JG. The handbook of infrared and Raman characteristic frequencies of organic molecules. Elsevier; 1991.
39.
go back to reference Nyquist RA, Kagel RO. Handbook of infrared and raman spectra of inorganic compounds and organic salts: infrared spectra of inorganic compounds. Academic press; 2012. Nyquist RA, Kagel RO. Handbook of infrared and raman spectra of inorganic compounds and organic salts: infrared spectra of inorganic compounds. Academic press; 2012.
40.
go back to reference Nakamoto K. Infrared and Raman spectra of inorganic and coordination compounds. Wiley Online Library; 1986. Nakamoto K. Infrared and Raman spectra of inorganic and coordination compounds. Wiley Online Library; 1986.
41.
go back to reference Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem. 2003;49:7–18.CrossRefPubMed Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem. 2003;49:7–18.CrossRefPubMed
42.
go back to reference Rutjes AW, Reitsma JB, Vandenbroucke JP, Glas AS, Bossuyt PM. Case-control and two-gate designs in diagnostic accuracy studies. Clin Chem. 2005;51:1335–41.CrossRefPubMed Rutjes AW, Reitsma JB, Vandenbroucke JP, Glas AS, Bossuyt PM. Case-control and two-gate designs in diagnostic accuracy studies. Clin Chem. 2005;51:1335–41.CrossRefPubMed
43.
go back to reference Flahault A, Cadilhac M, Thomas G. Sample size calculation should be performed for design accuracy in diagnostic test studies. J Clin Epidemiol. 2005;58:859–62.CrossRefPubMed Flahault A, Cadilhac M, Thomas G. Sample size calculation should be performed for design accuracy in diagnostic test studies. J Clin Epidemiol. 2005;58:859–62.CrossRefPubMed
44.
go back to reference Hall KA, Newton PN, Green MD, De Veij M, Vandenabeele P, Pizzanelli D, et al. Characterization of counterfeit artesunate antimalarial tablets from southeast Asia. Am J Trop Med Hyg. 2006;75:804–11.PubMed Hall KA, Newton PN, Green MD, De Veij M, Vandenabeele P, Pizzanelli D, et al. Characterization of counterfeit artesunate antimalarial tablets from southeast Asia. Am J Trop Med Hyg. 2006;75:804–11.PubMed
45.
go back to reference Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998;17:857–72.CrossRefPubMed Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998;17:857–72.CrossRefPubMed
46.
go back to reference Newcombe RG. Improved confidence intervals for the difference between binomial proportions based on paired data. Stat Med. 1998;17:2635–50.CrossRefPubMed Newcombe RG. Improved confidence intervals for the difference between binomial proportions based on paired data. Stat Med. 1998;17:2635–50.CrossRefPubMed
47.
go back to reference Bate R, Tren R, Hess K, Mooney L, Porter K. Pilot study comparing technologies to test for substandard drugs in field settings. Afr J Pharm Pharmacol. 2009;3:165–70. Bate R, Tren R, Hess K, Mooney L, Porter K. Pilot study comparing technologies to test for substandard drugs in field settings. Afr J Pharm Pharmacol. 2009;3:165–70.
Metadata
Title
The diagnostic accuracy of the hand-held Raman spectrometer for the identification of anti-malarial drugs
Authors
Benjamin J. Visser
Sophia G. de Vries
Emmanuel B. Bache
Janneke Meerveld-Gerrits
Daniëlle Kroon
Jimmy Boersma
Selidji T. Agnandji
Michèle van Vugt
Martin P. Grobusch
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2016
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-016-1212-y

Other articles of this Issue 1/2016

Malaria Journal 1/2016 Go to the issue